11beta-methyl-19-nortestosterone 17beta-dodecylcarbonate (University of Washington/Los Angeles Biomedical Research Institute/Eunice Kennedy Shriver National Institute of Child Health and Human Development)

N/A

Report date: 2025/06/09 17:38:17
NME

Base Information

Drug Name11beta-methyl-19-nortestosterone 17beta-dodecylcarbonate (University of Washington/Los Angeles Biomedical Research Institute/Eunice Kennedy Shriver National Institute of Child Health and Human Development)
Drug Alias Name11beta-MNTDC
ClassificationSmall molecules > Steroids
Mechanisms of ActionNAD(+) hydrolase SARM1 modulators
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsContraception
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsContraception
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A